My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 227

    1.

    Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.

    Cagir B, Gelmann A, Park J, Fava T, Tankelevitch A, Bittner EW, Weaver EJ, Palazzo JP, Weinberg D, Fry RD, Waldman SA.

    Ann Intern Med. 1999 Dec 7;131(11):805-12.PMID: 10610624 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.

    Waldman SA, Cagir B, Rakinic J, Fry RD, Goldstein SD, Isenberg G, Barber M, Biswas S, Minimo C, Palazzo J, Park PK, Weinberg D.

    Dis Colon Rectum. 1998 Mar;41(3):310-5.PMID: 9514425 [PubMed - indexed for MEDLINE]Related articles

    3.

    Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.

    Waldman SA, Hyslop T, Schulz S, Barkun A, Nielsen K, Haaf J, Bonaccorso C, Li Y, Weinberg DS.

    JAMA. 2009 Feb 18;301(7):745-52.PMID: 19224751 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.

    Chen G, McIver CM, Texler M, Lloyd JM, Rieger N, Hewett PJ, Sen Wan D, Hardingham JE.

    Dis Colon Rectum. 2004 May;47(5):679-86. Epub 2004 Mar 25.PMID: 15037935 [PubMed - indexed for MEDLINE]Related articles

    5.

    Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.

    Bustin SA, Siddiqi S, Ahmed S, Hands R, Dorudi S.

    Int J Cancer. 2004 Jan 20;108(3):412-7.PMID: 14648708 [PubMed - indexed for MEDLINE]Related articles

    6.

    A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.

    Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA.

    Clin Cancer Res. 2006 Aug 1;12(15):4545-52.PMID: 16899600 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.

    Conzelmann M, Dieterle CP, Linnemann U, Berger MR.

    Int J Cancer. 2003 Nov 20;107(4):617-28.PMID: 14520701 [PubMed - indexed for MEDLINE]Related articles

    8.

    Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.

    Nosotti M, Falleni M, Palleschi A, Pellegrini C, Alessi F, Bosari S, Santambrogio L.

    Chest. 2005 Sep;128(3):1539-44.PMID: 16162755 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.

    Fava TA, Desnoyers R, Schulz S, Park J, Weinberg D, Mitchell E, Waldman SA.

    J Clin Oncol. 2001 Oct 1;19(19):3951-9.PMID: 11579116 [PubMed - indexed for MEDLINE]Related articles

    10.

    Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20.

    Futamura M, Takagi Y, Koumura H, Kida H, Tanemura H, Shimokawa K, Saji S.

    J Surg Oncol. 1998 May;68(1):34-40.PMID: 9610661 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.

    Bernini A, Spencer M, Frizelle S, Madoff RD, Willmott LD, McCormick SR, Niehans GA, Ho SB, Kratzke RA.

    Cancer Detect Prev. 2000;24(1):72-9.PMID: 10757125 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.

    Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, Fukunaga H, Miyake Y, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, Monden M.

    J Clin Oncol. 2002 Oct 15;20(20):4232-41.PMID: 12377967 [PubMed - indexed for MEDLINE]Related articles

    13.

    Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques.

    Kassis ES, Nguyen N, Shriver SP, Siegfried JM, Schauer PR, Luketich JD.

    JSLS. 1998 Oct-Dec;2(4):331-6.PMID: 10036123 [PubMed - indexed for MEDLINE]Related articles

    14.

    Micrometastases and survival in stage II colorectal cancer.

    Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA.

    N Engl J Med. 1998 Jul 23;339(4):223-8.PMID: 9673300 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen.

    Ho SB, Hyslop A, Albrecht R, Jacobson A, Spencer M, Rothenberger DA, Niehans GA, D'Cunha J, Kratzke RA.

    Clin Cancer Res. 2004 Sep 1;10(17):5777-84.PMID: 15355906 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer.

    Carlson MR.

    Mol Diagn Ther. 2009;13(1):11-4. doi: 10.2165/01250444-200913010-00002. Review.PMID: 19351210 [PubMed - indexed for MEDLINE]Related articles

    17.

    Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.

    Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA.

    Expert Rev Mol Diagn. 2005 Sep;5(5):701-13. Review.PMID: 16149873 [PubMed - indexed for MEDLINE]Related articles

    18.

    Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.

    Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H, Akiyoshi T.

    Cancer Res. 1995 Aug 1;55(15):3417-20.PMID: 7542169 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

    Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

    Cancer Res. 2001 Mar 15;61(6):2523-32.PMID: 11289125 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

    Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

    Ann Surg. 2007 Dec;246(6):1040-6.PMID: 18043108 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity